GSE Systems, Inc. (GVP) Trades at $3.10 After Triangle; Egalet (EGLT) Shorts Decreased By 11.28%

Egalet Corporation (NASDAQ:EGLT) Logo

GSE Systems, Inc. (GVP) formed triangle with $3.26 target or 5.00% above today’s $3.10 share price. GSE Systems, Inc. (GVP) has $60.88M valuation. The stock decreased 1.59% or $0.05 during the last trading session, reaching $3.1. About 3,962 shares traded. GSE Systems, Inc. (NASDAQ:GVP) has declined 3.08% since June 14, 2017 and is downtrending. It has underperformed by 15.65% the S&P500. Some Historical GVP News: ; 02/04/2018 – Mortge Nws [Reg]: Opinion Time’s up: GSE reform ain’t happening this year; 24/04/2018 – WARNER WON’T RULE OUT CONGRESS TAKING UP GSE OVERHAUL IN 2018; 14/05/2018 – GSE Systems: Agreement Consists of 5-Year, $25 Million Delayed Draw Term Loan Facility; 17/05/2018 – CURRENT CONGRESS WON’T PASS A BIPARTISAN GSE BILL: HENSARLING; 23/05/2018 – CORKER ACKNOWLEDGES GSE LEGISLATIVE ACTION WON’T HAPPEN SOON; 17/05/2018 – HENSARLING COMMENTS ON GSE BILL AT EVENT IN WASHINGTON; 13/04/2018 – Moody’s Upgrades $1.1 Billion Of Gse Credit Risk Transfer (CRT) Rmbs Issued In 2016 And 2017; 14/05/2018 – GSE SYSTEMS INC – TRANSACTION ANTICIPATED TO BE IMMEDIATELY ACCRETIVE TO GSE’S ADJUSTED EARNINGS; 14/05/2018 – GSE SYSTEMS INC – DEAL FOR $9.75 MLN; 15/03/2018 – GSE Systems 4Q Loss/Shr 1c

Egalet Corporation (NASDAQ:EGLT) had a decrease of 11.28% in short interest. EGLT’s SI was 7.26M shares in June as released by FINRA. Its down 11.28% from 8.19M shares previously. With 1.71 million avg volume, 4 days are for Egalet Corporation (NASDAQ:EGLT)’s short sellers to cover EGLT’s short positions. The stock decreased 6.98% or $0.0353 during the last trading session, reaching $0.4702. About 762,973 shares traded or 11.54% up from the average. Egalet Corporation (NASDAQ:EGLT) has declined 81.41% since June 14, 2017 and is downtrending. It has underperformed by 93.98% the S&P500. Some Historical EGLT News: ; 07/05/2018 – EGALET – A NATIONAL PHARMACY BENEFIT MANAGER HAS PLACED ARYMO ER EXTENDED-RELEASE TABLETS FOR ORAL USE ONLY -Cll IN TIER 3 UNRESTRICTED POSITION; 08/05/2018 – EGALET CORP – NET PRODUCT SALES OF $6.3 MLN FOR QUARTER ENDED MARCH 31, 2018 COMPARED TO $5.4 MLN; 29/05/2018 – EGALET CORP – LARGE SOUTHEAST REGIONAL HEALTH PLAN PLACED SPRIX NASAL SPRAY IN TIER 3 COVERED POSITION EFFECTIVE IMMEDIATELY; 07/05/2018 – EGALET CORP – A NATIONAL PHARMACY BENEFIT MANAGER HAS PLACED SPRIX NASAL SPRAY IN A TIER 2 PREFERRED POSITION EFFECTIVE IMMEDIATELY; 07/05/2018 – EGALET SAYS PBM TO COVER SPRIX NASAL SPRAY & ARYMO ER; 29/05/2018 – Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray; 08/05/2018 – Egalet 1Q Loss/Shr 26c; 12/03/2018 Egalet 4Q EPS 3c; 21/04/2018 – DJ Egalet Corporation, Inst Holders, 1Q 2018 (EGLT); 08/05/2018 – Egalet 1Q Loss $12.4M

Another recent and important Egalet Corporation (NASDAQ:EGLT) news was published by which published an article titled: “FDA OKs first non-opioid treatment for opioid withdrawal” on May 16, 2018.

Among 5 analysts covering Egalet Ltd (NASDAQ:EGLT), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Egalet Ltd had 15 analyst reports since November 4, 2015 according to SRatingsIntel. The company was maintained on Friday, August 25 by Cantor Fitzgerald. JMP Securities maintained the stock with “Market Outperform” rating in Friday, July 14 report. Cantor Fitzgerald maintained it with “Buy” rating and $7.0 target in Wednesday, November 8 report. JMP Securities maintained Egalet Corporation (NASDAQ:EGLT) rating on Friday, June 9. JMP Securities has “Buy” rating and $1500 target. Cantor Fitzgerald maintained it with “Buy” rating and $800 target in Thursday, June 1 report. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, March 12. The stock of Egalet Corporation (NASDAQ:EGLT) earned “Buy” rating by Cantor Fitzgerald on Tuesday, June 13. The rating was maintained by Cantor Fitzgerald with “Buy” on Monday, September 11. Cantor Fitzgerald maintained it with “Buy” rating and $700 target in Monday, August 14 report. The firm has “Hold” rating by Stifel Nicolaus given on Wednesday, January 3.

Egalet Corporation, a specialty pharmaceutical company, develops, makes, and commercializes treatments for patients with pain and other conditions. The company has market cap of $24.85 million. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic moderate to severe pain where an opioid is appropriate; and ARYMO ER, an extended-release morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It currently has negative earnings. The firm is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER.

Investors sentiment increased to 0.7 in 2018 Q1. Its up 0.23, from 0.47 in 2017Q4. It improved, as 8 investors sold Egalet Corporation shares while 12 reduced holdings. 4 funds opened positions while 10 raised stakes. 12.28 million shares or 9.88% less from 13.62 million shares in 2017Q4 were reported. Parallax Volatility Advisers L P accumulated 480,254 shares. 4,296 are owned by National Bank & Trust Of America Corporation De. Barclays Public Ltd Com holds 0% of its portfolio in Egalet Corporation (NASDAQ:EGLT) for 65 shares. 15,000 are held by Atlantic Grp Inc Ltd Llc. Janney Montgomery Scott Ltd Company reported 0% of its portfolio in Egalet Corporation (NASDAQ:EGLT). Highland Mngmt Ltd Partnership accumulated 119,520 shares or 0% of the stock. Stifel Financial Corporation reported 0% in Egalet Corporation (NASDAQ:EGLT). 10,059 are held by Tiverton Asset Mgmt Ltd Liability Corporation. Two Sigma Llc reported 20,372 shares stake. Highbridge Capital Management Ltd Liability Com owns 0.03% invested in Egalet Corporation (NASDAQ:EGLT) for 3.23M shares. Goldman Sachs Gp Inc reported 153,695 shares or 0% of all its holdings. Blackrock owns 431,393 shares. Hightower Advisors Ltd holds 277,025 shares or 0% of its portfolio. Alyeska Investment Limited Partnership has 834,880 shares for 0% of their portfolio. Geode Cap Management Ltd Liability Corp stated it has 0% of its portfolio in Egalet Corporation (NASDAQ:EGLT).

Investors sentiment decreased to 0.63 in Q1 2018. Its down 0.08, from 0.71 in 2017Q4. It fall, as 1 investors sold GSE Systems, Inc. shares while 7 reduced holdings. 2 funds opened positions while 3 raised stakes. 4.71 million shares or 5.45% more from 4.46 million shares in 2017Q4 were reported. Teton Advsrs reported 0.01% stake. Spark Investment Mngmt Lc has invested 0% of its portfolio in GSE Systems, Inc. (NASDAQ:GVP). 567,199 are owned by Renaissance Technologies Ltd Llc. S Squared Lc owns 808,162 shares. Bridgeway Cap reported 240,125 shares or 0.01% of all its holdings. Vantage Inv Advisors Limited Liability Co has invested 0% in GSE Systems, Inc. (NASDAQ:GVP). Cove Street Capital Limited Co invested in 0.09% or 262,640 shares. Royal Bank & Trust Of Canada reported 0% stake. Natl Bank Of Montreal Can reported 0% of its portfolio in GSE Systems, Inc. (NASDAQ:GVP). California Employees Retirement System has 147,100 shares. 92,912 were accumulated by Blackrock. Needham Inv Management Limited Liability Corp invested in 1.04% or 1.12 million shares. Barclays Public Lc accumulated 1 shares. Wealthtrust Axiom Limited Liability Co invested in 0.02% or 19,222 shares. Panagora Asset owns 9,164 shares or 0% of their US portfolio.

GSE Systems, Inc. (NASDAQ:GVP) Institutional Positions Chart